Montero-Fernandez N, Serra-Rexach JA
Pharmacotherapy: semaglutide treatment GLP-1 Receptor Agonists (GLP-1 RAs) are a group of medications used to treat type 2 diabetes and obesity by mimicking the incretin hormone GLP-1, thereby promoting blood glucose reduction and weight loss, along with providing added advantages such as lowering cardiovascular and renal risk
Magnetic Resonance Spectroscopy (MRS) can be used to quantify neurometabolites non-invasively
Adonis Saremi delivers physician-supervised GLP-1 therapy with the clinical thoroughness it demands matching each patient to the right agent, managing titration personally, and supporting results with a complete metabolic health program
It should be consumed together with another source of protein like dairy, meat/poultry, eggs, or high-quality plant proteins like legumes
Artzi Z, Weinreb M, Tal H, Nemcovsky CE, Rohrer MD, Prasad HS, et al